ATE124258T1 - Schilddrüsenhormone zur kardialen behandlung. - Google Patents

Schilddrüsenhormone zur kardialen behandlung.

Info

Publication number
ATE124258T1
ATE124258T1 AT91904573T AT91904573T ATE124258T1 AT E124258 T1 ATE124258 T1 AT E124258T1 AT 91904573 T AT91904573 T AT 91904573T AT 91904573 T AT91904573 T AT 91904573T AT E124258 T1 ATE124258 T1 AT E124258T1
Authority
AT
Austria
Prior art keywords
cardial
treatment
thyroid hormones
thyroid
hormones
Prior art date
Application number
AT91904573T
Other languages
English (en)
Inventor
Leo Rubin
Original Assignee
British Tech Group Usa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group Usa filed Critical British Tech Group Usa
Application granted granted Critical
Publication of ATE124258T1 publication Critical patent/ATE124258T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
AT91904573T 1990-02-05 1991-02-05 Schilddrüsenhormone zur kardialen behandlung. ATE124258T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47536090A 1990-02-05 1990-02-05
US49535490A 1990-03-19 1990-03-19

Publications (1)

Publication Number Publication Date
ATE124258T1 true ATE124258T1 (de) 1995-07-15

Family

ID=27044760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91904573T ATE124258T1 (de) 1990-02-05 1991-02-05 Schilddrüsenhormone zur kardialen behandlung.

Country Status (7)

Country Link
EP (1) EP0466909B1 (de)
JP (1) JP3084059B2 (de)
AT (1) ATE124258T1 (de)
CA (1) CA2051369C (de)
DE (1) DE69110779T2 (de)
GB (1) GB2240474B (de)
WO (1) WO1991011181A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
SE501834C2 (sv) * 1993-09-22 1995-05-22 Moelnlycke Ab Superabsorberande fiber eller fibertyg, förfarande för dess framställning samt absorberande alster innefattande den
CA2432523C (en) * 2000-12-21 2014-06-03 Resuscitek, Inc. Compositions of stable t3 and methods of use thereof
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
JP2007512359A (ja) 2003-11-19 2007-05-17 メタバシス・セラピューティクス・インコーポレイテッド 新規なリン含有甲状腺ホルモン様物質
DK1811987T3 (da) 2004-11-18 2008-07-14 Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa Törpulver omfattende levothyroxinnatrium indgivet via inhalator
MX2007014502A (es) 2005-05-26 2008-02-07 Metabasis Therapeutics Inc Tiromimeticos para el tratamiento de enfermedades del higado graso.
US20120190748A1 (en) * 2009-08-04 2012-07-26 Haren Treasurer Greater utility with thyroid hormone
JP2020500199A (ja) 2016-11-21 2020-01-09 バイキング・セラピューティクス・インコーポレイテッド グリコーゲン蓄積症の治療方法
EA201992703A1 (ru) 2017-06-05 2020-04-15 Вайкинг Терапьютикс, Инк. Композиции для лечения фиброза
CN112135832A (zh) 2018-03-22 2020-12-25 维京治疗公司 化合物的晶型和制备化合物的晶型的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622703A5 (en) * 1976-06-10 1981-04-30 Berema Sa Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite
JPH07116031B2 (ja) * 1986-09-24 1995-12-13 株式会社アドバンス 制癌剤
SE461013B (sv) * 1988-02-11 1989-12-18 Christian Wesslau Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon

Also Published As

Publication number Publication date
GB9102430D0 (en) 1991-03-20
DE69110779T2 (de) 1995-12-07
CA2051369C (en) 2002-01-01
DE69110779D1 (de) 1995-08-03
JP3084059B2 (ja) 2000-09-04
JPH04506667A (ja) 1992-11-19
CA2051369A1 (en) 1991-08-06
GB2240474B (en) 1994-01-12
EP0466909A1 (de) 1992-01-22
GB2240474A (en) 1991-08-07
WO1991011181A1 (en) 1991-08-08
EP0466909B1 (de) 1995-06-28

Similar Documents

Publication Publication Date Title
NO884259L (no) Doseringsanordning til behandling av kardiovaskulaere sykdommer.
DE69307509T2 (de) Vorrichtung zur behandlung von herzfehlern
DE3855489D1 (de) Behandlung von Hautfalten
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69019488T2 (de) Behandlung von Geflügel.
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
ATE124258T1 (de) Schilddrüsenhormone zur kardialen behandlung.
DE3785740T2 (de) Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie.
DK617687A (da) Bestraalingsanordning til medicinsk behandling
DE3854121T2 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE3687692D1 (de) Geschlechtshormone zur behandlung von immun-mangel-krankheiten.
DK360687D0 (da) Bestraalingsanordning til medicinsk behandling
DK152587A (da) Bestraalingsanordning til medicinsk behandling
NO880292D0 (no) Fremgangsmaate for behandling av humle.
DK24887D0 (da) Bestraalingsanordning til medicinsk behandling
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DK24587D0 (da) Bestraalingsanordning til medicinsk behandling
DK650087A (da) Bestraalingsanordning til medicinsk behandling
JPS5547857A (en) Appliance for medical treatment
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
JPS54128195A (en) Appliance for medical treatment
FI831258A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara benzimidazolderivat
RO81783A3 (ro) Medicament pentru tratamentul maladiei neoplazice

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties